Cardiovascular Safety and Benefits of PDE-5 Inhibition in Women with Female Sexual Dysfunction (FSD)

[madman]

 

[madman]

*The introduction in 1982 of vasoactive agents for intracavernous injection represents a milestone in the diagnosis and treatment of erectile dysfunction

*Papaverine was introduced in the early 1980s as the first effective intracavernosal injection treatment for erectile dysfunction


post #9

Intracavernosal injection therapy in erectile dysfunction

Current status of intracavernosal injection therapy in erectile dysfunction (2023) Bobo W. Elena, Melchiode Zachary, Pavaluri Haritha, Bobo A. Graham & Hellstrom J.G. Wayne Abstract Introduction Erectile dysfunction (ED) is defined as the inability to attain and/or maintain a penile...

www.excelmale.com

 

[madman]

Ground breaking!

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]